A Study to Evaluate the Safety and Tolerability of ABBV-951 in Participants With Parkinson's Disease (PD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03781167

Recruitment Status : Enrolling by invitation

First Posted : December 19, 2018

Last Update Posted : April 1, 2021

Sponsor:

Information provided by (Responsible Party):

AbbVie

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Enrolling by invitation
Estimated Primary Completion Date :	July 4, 2022
Estimated Study Completion Date :	July 4, 2022

To Top